Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Norton Rose Fulbright Canada LLP
The Agricultural Growth Act (Bill C-18) was recently passed by Canada's House of Commons and is now in its final stages of becoming law.
Norton Rose Fulbright Canada LLP
Tim Hortons Inc. has agreed to be purchased by Burger King Worldwide, Inc., which would create the third-largest fast food company in the world.
Norton Rose Fulbright Canada LLP
In early December 2014, an outbreak of H5N2 strain of avian influenza was found in BC.
Miller Thomson LLP
Catherine Bate & Kelly Harris have prepared a piece for Global Advertising Lawyers Alliance (GALA) on "New Nutrition Criteria for Food Advertising to Children."
Norton Rose Fulbright Canada LLP
A report from the Patented Medicine Prices Review Board (PMPRB) compares generic drug prices in Canada with those of other industrialized countries.
Miller Thomson LLP
Despite the fact that this is the third ruling the WTO has made against the United States’ meat-labelling laws in five years, the U.S. is appealing this most recent decision.
Miller Thomson LLP
The Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) was passed by the federal legislature and received Royal Assent on November 6, 2014.
Norton Rose Fulbright Canada LLP
Apotex Inc. ("Apotex") had commenced an action for damages, including punitive damages, against Health Canada for its failure to issue a Notice of Compliance ("NOC") for its product Apo-Trazad until the lapse of a period of seven years.
Norton Rose Fulbright Canada LLP
On September 30, 2014, Health Canada took action to ban the import of finished drug products and active pharmaceutical ingredients ("API") from the following sites located in India: Apotex Pharmachem India Pvt Ltd (APIPL), Apotex Research Private Limited (ARPL) and IPCA Laboratories.
Osler, Hoskin & Harcourt LLP
On November 5, 2014, the Ontario Ministry of Health and Long-Term Care posted proposed amendments to O. Reg. 201/96 made under the Ontario Drug Benefit Act.
Borden Ladner Gervais LLP
In 1988, Apotex Inc. ("Apotex") filed a submission for approval of its trazodone product with Health Canada. The Apotex product was ultimately approved in 1995, at which time two other generic companies already had approval in respect of their trazodone products.
Borden Ladner Gervais LLP
Hamilton Health Sciences Corporation v. D.H., 2014 ONCJ 603, Ontario Court of Justice (G.B. Edward J.), 14 November 2014.
Gowling Lafleur Henderson LLP
On July 16, 2014 the federal government finalized a regulatory amendment extending the system of Administrative Monetary Penalties to the Meat inspection Act and Regulations.
Gowling Lafleur Henderson LLP
In Part I, this column explained that the extension of Admin­istrative Monetary Penalties or AMPs to the Meat Inspection Act and Regulations was a significant development in Canadian food law.
Miller Thomson LLP
This is our fourth post on Bill C-18 and its and its proposed amendments to the Plant Breeders’ Rights Act (PBRA)
Cassels Brock
The basis for the issuance of the above orders differs depending on which order the Minister wishes to make.
Torys LLP
The Ontario Ministry of Health and Long-Term Care has proposed amendments to the regulations made under the Ontario Drug Benefit Act.
Miller Thomson LLP
In Broader Public Sector Accountability Bill Re-introduced, we provided an overview of Bill 8, the proposed Public Sector and MPP Accountability and Transparency Act, 2014.
Bull, Housser & Tupper LLP
On October 29, 2014, Madam Justice Adair issued an oral decision interpreting section 46(6) of the Hospital Act for the first time.
Borden Ladner Gervais LLP
On July 8, 2014, the Ontario government re-introduced Bill 8, formerly Bill 179, which proposes to amend several laws affecting health sector organizations
Latest Video
Most Popular Recent Articles
Norton Rose Fulbright Canada LLP
The Government of Quebec tabled Bill 10, "An Act to modify the organization and governance of the health and social services network, in particular by abolishing the regional agencies."
Norton Rose Fulbright Canada LLP
There have been a number of notable developments in recent weeks in respect of patent utility law in Canada.
Davis LLP
On November 6, 2014, Bill C-17 (the Protecting Canadians from Unsafe Drugs Act, aka Vanessa’s Law) (the "Act") received Royal Assent and came into law.
Norton Rose Fulbright Canada LLP
On September 30, 2014, Health Canada took action to ban the import of finished drug products and active pharmaceutical ingredients ("API") from the following sites located in India: Apotex Pharmachem India Pvt Ltd (APIPL), Apotex Research Private Limited (ARPL) and IPCA Laboratories.
McMillan LLP
Medical marijuana has been making headlines in Canada after sweeping changes to regulations created a new market for commercial marijuana production.
Miller Thomson LLP
Bill C-17, the Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) was passed by the federal legislature and received Royal Assent on November 6, 2014.
Blake, Cassels & Graydon LLP
Bill C-17, An Act to Amend the Food and Drugs Act, received royal assent on November 6, 2014.
Norton Rose Fulbright Canada LLP
The Nagoya Protocol on Access and Benefit-sharing (the Protocol), adopted in 2010 by the parties to the Convention on Biological Diversity (the Convention), entered into force in October 2014.
Borden Ladner Gervais LLP
In 1988, Apotex Inc. ("Apotex") filed a submission for approval of its trazodone product with Health Canada. The Apotex product was ultimately approved in 1995, at which time two other generic companies already had approval in respect of their trazodone products.
Bennett Jones LLP
The Marihuana for Medical Purposes Regulations is a new set of rules for growing, purchasing and selling medical marijuana in Canada.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners